BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10768648)

  • 21. Causes of Death in Cutaneous T-Cell Lymphoma Patients.
    Lebas E; Collins P; Somja J; Nikkels AF
    Dermatology; 2023; 239(6):860-867. PubMed ID: 37611553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC).
    Kempf W; Ostheeren-Michaelis S; Paulli M; Lucioni M; Wechsler J; Audring H; Assaf C; Rüdiger T; Willemze R; Meijer CJ; Berti E; Cerroni L; Santucci M; Hallermann C; Berneburg M; Chimenti S; Robson A; Marschalko M; Kazakov DV; Petrella T; Fraitag S; Carlotti A; Courville P; Laeng H; Knobler R; Golling P; Dummer R; Burg G;
    Arch Dermatol; 2008 Dec; 144(12):1609-17. PubMed ID: 19075143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis.
    Tsang Y; Gu T; Sharma G; Raspa S; Drake B; Tan H
    J Dermatolog Treat; 2018 Dec; 29(8):747-753. PubMed ID: 29733229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
    Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
    J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adnexotropic and granulomatous mycosis fungoides following TNF-α inhibitor treatment.
    Doughty H; Scripture A; Carter JB; Sriharan A; Yan S; Lansigan F; Momtahen S
    J Cutan Pathol; 2023 Jul; 50(7):611-616. PubMed ID: 37127841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
    Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
    J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of symptoms does not correlate with results of T-cell gene rearrangement studies in patients evaluated for cutaneous T-cell lymphoma.
    Larson AR; Rodig S; Granter SR
    J Cutan Pathol; 2015 Sep; 42(9):618-21. PubMed ID: 25931314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
    Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
    Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome.
    Hashida Y; Nakajima K; Higuchi T; Nakai K; Daibata M
    J Clin Virol; 2023 Aug; 165():105523. PubMed ID: 37336173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early mycosis fungoides: can the diagnosis be made reliably?
    Cook DL
    Adv Anat Pathol; 2001 Jul; 8(4):240-4. PubMed ID: 11444511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressive cutaneous T-cell lymphomas.
    Junkins-Hopkins Md JM
    Semin Diagn Pathol; 2017 Jan; 34(1):44-59. PubMed ID: 28187925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D in Cutaneous T-Cell Lymphoma.
    Ødum AF; Geisler C
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of cutaneous T-cell clonality analysis for the diagnosis of cutaneous T-cell lymphoma in patients with erythroderma.
    Cordel N; Lenormand B; Courville P; Helot MF; Benichou J; Joly P;
    Arch Pathol Lab Med; 2005 Mar; 129(3):372-6. PubMed ID: 15737033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic criteria for early diagnosis of cutaneous T-cell lymphoma.
    Smith NP
    Dermatol Clin; 1994 Apr; 12(2):315-22. PubMed ID: 8045042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.